NEWDIGS Team
Program Director
Gigi Hirsch, MD
ghirsch@mit.edu
617-253-9609
Lynn Baird, PhD
Director, Regulatory Sciences
lbaird@mit.edu
617-324-4842
Chester Drum MD, PhD
Director, Translational Medicine
Director, NEWDIGS – Asia
cdrum@mit.edu
617-253-0257
Jennifer L. Wilkins
Program Manager
wilkins@mit.edu
617-324-4841
Affiliated Faculty and Researchers
- Jeff Brown, PhD, Assistant Professor, Department of Population Medicine, Harvard Medical School
- Charles Cooney, PhD, Robert T. Haslam Professor of Chemical Engineering, MIT; Faculty Director, Deshpande Center for Technological Innovation
- Chester Drum, MD, PhD, Director, Translational Medicine, CBI, MIT; Director, NEWDIGS-Asia
- Hans-Georg Eichler, MD, MSc, Senior Medical Officer, European Medicines Agency (EMA)
- Stan Finkelstein, MD, Assistant Professor of Medicine, Harvard Medical School; Senior Research Scientist, Harvard-MIT Division of Health Sciences and Technology (HST)
- Judith Maro, PhD student, Engineering Systems Division, MIT
- Lawrence McCray, PhD, Project on Knowledge and Decision-making, MIT; Former (Founding) Director of the Policy Division of the National Research Council – National Academy of Sciences
- Kenneth Oye, PhD, Associate Professor of Political Science, Co-Director, MIT Program on Emerging Technologies, MIT
- Nitin Patel, PhD, Research Affiliate, MIT Center for Biomedical Innovation; Founder, Chairman, and Chief Technology Officer, Cytel Statistical Software and Services
- Luis Perez-Breva, PhD, Research Scientist and Lecturer, Innovation Teams and School of Engineering, MIT
- GK Raju, PhD, CBI Distinguished Fellow; Chairman, CBI Biomanufacturing Steering Committee; Executive Director, MIT Pharmaceutical Manufacturing Initiative
- Ram Sasisekharan, PhD, Director, Harvard – MIT Health Sciences and Technology, Edward Hood Taplin Professor of Health Sciences & Technology and Biological Engineering, MIT
- Anthony Sinskey, ScD, Faculty Director, CBI; Professor of Biology and Health Sciences and Technology, MIT
- Phillip Sharp, PhD, Institute Professor, Koch Institute for Integrative Cancer Research, MIT
Sponsors and Collaborators
- Aetna (http://www.aetna.com/)
- Broad Institute (http://www.broadinstitute.org/)
- Bristol-Myers Squibb * (http://www.bms.com/)
- Dana Farber Cancer Institute (http://www.dana-farber.org/)
- Dr. Miriam & Sheldon G. Adelson Medical Research Foundation (http://www.adelsonfoundation.org/)
- European Medicines Agency (EMA) (http://www.ema.europa.eu/)
- GlaxoSmithKline* (http://www.gsk.com/)
- Harvard Medical School (http://hms.harvard.edu/)
- Health Canada (http://www.hc-sc.gc.ca/index-eng.php)
- Health Sciences Authority (HSA) (http://www.hsa.gov.sg/)
- Johnson & Johnson * (http://www.jnj.com/connect/)
- KEW Group, LLC (http://www.kewgroupllc.com/)
- Life Technologies (http://www.lifetechnologies.com/)
- Massachusetts General Hospital Cancer Center (http://www.massgeneral.org/)
- Memorial Sloan-Kettering Cancer Center (http://www.mskcc.org/)
- Merck Serono (http://www.merckserono.com/)
- MIT (http://www.mit.edu)
- NICE (http://www.nice.org.uk)
- Pfizer * (http://www.pfizer.com)
- Quintiles * (http://www.quintiles.com)
- sanofi (http://www.sanofi.com/)
* CBI is grateful to these members for their generous financial support and commitment
